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Abstract: A 69-year-old woman with a history of uT2 N0 post-treated anal squamous cell cancer (SCC) presented for EUS 
for perianal pain. Two months prior, a digital rectal examination was signiﬁ  cant for an indurated lesion on the left lateral 
rectal wall just proximal to the dentate line. A sigmoidoscopy revealed mild narrowing of the anal canal and an ulcerated 
friable mucosa in the same area. A biopsy demonstrated ulceration without malignancy. EUS showed a hypoechoic, non-
circumferential, left-sided distal rectal mass. EUS-FNA was performed. Cytology demonstrated poorly differentiated SCC. 
This was conﬁ  rmed by subsequent surgical resection. While endoscopic biopsy of suspected anal recurrences is usually 
sufﬁ  cient, histologic or cytologic conﬁ  rmation are necessary, as radiation-induced changes are difﬁ  cult to differentiate from 
tumor recurrence. This case demonstrates that EUS-FNA is useful in surveillance of anal SCC when there is a high clinical 
suspicion of recurrence.
Introduction
Anal squamous cell cancer (SCC) is an uncommon disease
1 that responds well to chemotherapy and 
radiation. There is no established standard for post treatment surveillance. Perianal tissue inﬂ  ammation 
occurring after radiation makes differentiation between recurrent cancer and radiation-induced injury 
difﬁ  cult.
2 We herein report a case of a woman with a history of anal SCC status post chemoradiation 
who presented with perianal pain and ulceration. She underwent lower endoscopy of the anal canal and 
rectum with negative biopsies on two separate occasions. She was referred for endoscopic ultrasound 
(EUS) with possible ﬁ  ne needle aspiration (EUS-FNA) of the anal canal.
Case Report
A 69-year-old white woman with a history signiﬁ  cant for hypothyroidism and neck immobilization was 
diagnosed with uT2 N0 anal squamous cell carcinoma (SCC) of the left lateral anal canal. She initially 
presented with perianal pain. A pelvic CT scan performed at the time of diagnosis was unremarkable. 
She underwent chemotherapy and external beam radiation. Her chemotherapy regimen consisted of 
mitomycin C and oral capcitebine. Following chemotherapy and radiation, a repeat lower endoscopy 
with an anal biopsy was performed which revealed persistent SCC in situ. She then underwent a second 
course of chemotherapy and radiation.
Four months later during follow up an indurated lesion on the left lateral rectal wall adjacent to the 
dentate line and an anal stricture was appreciated on digital rectal examination. A gastroenterologist 
performed a sigmoidoscopy which was signiﬁ  cant for a left lateral rectal ulcer and an anal canal stricture. 
Biopsies were taken from the rectal ulcer and anal dilation was performed. The biopsies were negative 
for malignancy. One month later, the patient presented with rectal bleeding and severe perianal pain 
exacerbated with defecation and sitting. A second sigmoidoscopy revealed mild narrowing of the anal 
canal and ulcerated friable mucosa in the left lateral distal rectum involving the anal canal. Repeat biop-
sies of the ulcerated mucosa in the rectum and anal canal demonstrated ulceration without malignancy.
One month later and 6 months after completing her second course of chemotherapy and radiation, 
she presented for EUS of the anal canal. Prior to the EUS, the gastroenterologist performed a digital 60
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rectal examination. The examination was signiﬁ  cant 
for exquisite tenderness and induration of the left 
lateral anal canal and distal rectal wall extending 
approximately 2 cm from the anal verge.
On radial EUS (Olympus GF-UM160, Center 
Valley, PA) examination a hypoechoic, left-sided 
distal rectal mass was seen (Fig.  1). The mass was 
non-circumferential with poorly deﬁ  ned borders. 
It encompassed approximately 50% of the 
circumference of the distal rectum (Fig. 2). The 
mass measured 18 mm in maximal thickness. 
Endoscopic ultrasound-guided fine needle 1 
(EUS-FNA) of this abnormal area was performed 
(Fig. 3). Seven passes were taken with a 22-gauge 
needle (Echotip, Wilson Cook, Winston Salem, 
NC) using a transrectal approach. On preliminary 
on-site cytologic evaluation, a few groups of 
atypical cells with inﬂ  ammation and necrosis were 
observed. The patient received a 1.5 g of ampicillin/
ulbactam intravenously after the procedure and 
amoxicillin/clavulanic acid 500 mg orally three 
times a day for seven days. Final cytology results 
demonstrated poorly differentiated SCC (Fig. 4).
The patient underwent abdominal perineal 
resection and colostomy. The posterior wall of the 
vagina, anus, and rectum were involved with 
poorly differentiated SCC (Fig. 5). The tumor 
extended to the subcutaneous tissue of the anus, 
with extensive perineural invasion. There was no 
evidence of lymphovascular invasion. Eight lymph 
nodes were negative for malignancy.
Discussion
Endoscopic ultrasound (EUS) provides accurate 
TNM staging and has been used to determine 
clinical responsiveness after treatment.
3 While 
endoscopic biopsies of suspected anal recurrences 
are usually sufﬁ  cient, histologic or cytologic con-
ﬁ  rmation is necessary, as radiation-induced changes 
are difﬁ  cult to differentiate from tumor recurrence. 
Symptoms and signs such as rectal bleeding, pain, 
skin changes, stricture, and proctitis may result 
from local recurrent disease or radiation-induced 
proctitis.
4 Clinical history and physical examination 
with careful rectal examination are mandatory. 
Endoscopic mucosal biopsy is a standard tool for 
histological diagnosis but may also cause perianal 
or rectal pain and bleeding.
5 Hence, endoscopic 
surveillance is usually performed at least 8 weeks 
after chemoradiation.
5 Computed tomography (CT) 
or EUS without FNA cannot reliably differentiate 
Figure 1. Radial EUS revealed a hypo-echoic, left-sided distal rectal 
mass.
Figure 2. The mass was non-circumferential with poorly deﬁ  ned 
borders and encompassed approximately 50% of the circumference 
of the distal rectum.
Figure 3. EUS-FNA of the tumor recurrence.61
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between tumor recurrence and radiation-induced 
changes in the gastrointestinal wall.
6,7
This case demonstrates the utility of EUS-FNA 
after non-diagnostic endoscopic biopsies were 
taken. The EUS-FNA cytopathology result was 
not able to differentiate between keratinizing and 
non-keratinizing SCC. However, given similar 
biology, prognosis and treatment, this differentia-
tion is not necessarily required for management of 
anal SCC.
8,9 Certainly, if the preliminary EUS-
FNA had been negative an alternative would be to 
obtain an EUS-guided core biopsy (19 gauge) of 
Figure 4. EUS-FNA aspirate (Hematoxylin and Eosin staining, 40 X) revealing poorly differentiated squamous cell carcinoma of the anal 
canal. Peripheral nuclear palisading cells are seen.
Figure 5. Surgical histology (Hematoxylin and Eosin staining, 40 X) revealing poorly differentiated squamous cell carcinoma.62
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the perianal canal for histologic assessment. This 
method acquires more tissue for histologic 
evaluation. In this particular case, had the 
EUS-FNA had been negative, the sonographic 
images of an irregular tumor combined with the 
clinical presentation would be sufﬁ  cient to send 
this patient to surgery for resection, given this 
patient’s debilitating pain. However, sonographic 
imaging of suspected recurrence in the gastroin-
testinal wall should be conﬁ  rmed cytologically or 
histologically in the absence of symptoms to 
suggest recurrence. Based on our experience, the 
hardness/stiffness of the target site and gross 
appearance of the aspirate are poor predictors of 
tumor recurrence in the gastrointestinal wall. We 
are not aware of any other features of the EUS-FNA 
procedure that would be predictive of recurrence 
in the gastrointestinal wall after chemotherapy and 
radiation.
To our knowledge, this is the only report of 
EUS-FNA used to diagnose post-treatment anal 
cancer recurrence after negative cold forceps biop-
sies. Our case demonstrates that EUS-FNA may 
be useful in surveillance of anal SCC following 
treatment when there is a high clinical suspicion 
of recurrence. Further prospective study of EUS 
surveillance of anal SCC recurrence is warranted 
in select patients.
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